A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer (Q60535584)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 January 2011

Language	Label	Description	Also known as
English	A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer	scientific article published on 15 January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

0 references

phase II clinical trial

1 reference

based on heuristic

inferred from title

recurrent endometrial cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rachel Isaksson Vogel

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Melissa A Geller

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Joseph J Ivy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Levi S Downs

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Patricia L Judson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Linda F Carson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Amy L Jonson

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kathryn Dusenbery

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Matthew P Boente

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter A Argenta

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

15 January 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

121

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

112-117

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: a study by the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: Unraveling a mystery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.338

7 January 2021

Is adjuvant therapy necessary for peritoneal cytology-positive surgical-pathologic Stage I endometrial cancer? Preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/21239048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evaluation of paclitaxel and carboplatin in patients with endometrial cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21239048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21239048

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2010.12.338

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21239048%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60535584&oldid=2153750976"